Zhejiang Orient Gene Biotech announced that the company will hold the 11th meeting of the 3rd Board of Directors and the 10th meeting of the 3rd Supervisory Board on December 27, 2024, to review and approve the "Proposal on the Postponement of Some Fundraising Projects." The company agreed to extend the expected operational status timeline of the "Technology Research and Development Center Construction Project" and the "Marketing Network and Information Technology Management Platform Construction Project" from the original plan of December 2024 to December 2025. This postponement does not change the investment content, total investment amount, or implementing entity of the fundraising projects. As of the end of November 2024, the cumulative investment amount for the Technology Research and Development Center Construction Project is 39.3197 million yuan, with a completion progress of 47.62%; the cumulative investment amount for the Marketing Network and Information Technology Management Platform Construction Project is 71.6702 million yuan, with a completion progress of 81.06%.